Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AMGN | VRTX | GILD | BMY |
| Company | Biomarin Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 66.32 | 322.00 | 493.70 | 94.00 | 55.19 |
| High | 67.12 | 322.97 | 503.45 | 98.32 | 55.52 |
| Low | 65.76 | 318.54 | 486.64 | 93.51 | 54.49 |
| Last | 67.06 | 322.00 | 503.98 | 97.36 | 55.02 |
| Change | +0.91 | +0.21 | +10.34 | +5.67 | -0.26 |
| % Change | +1.38% | +0.07% | +2.09% | +6.18% | -0.47% |
| Volume | 687,145 | 883,935 | 524,035 | 10,211,005 | 8,141,312 |
| 20-Day Average Volume | 1,461,964 | 1,742,640 | 1,075,030 | 5,593,424 | 8,825,651 |
| Previous Close | 66.15 | 321.79 | 493.64 | 91.69 | 55.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 68.81 | 319.73 | 481.49 | 88.40 | 53.50 |
| 20-Day Raw Stochastic | 30.82% | 61.00% | 89.33% | 88.34% | 70.86% |
| 20-Day Relative Strength | 36.13% | 50.82% | 60.53% | 80.59% | 60.57% |
| Weighted Alpha | -26.67 | +18.11 | +33.50 | +40.23 | +16.10 |
| Today's Opinion | 100% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 8% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.81% since 10/31/24 | +0.56% since 10/31/24 | +5.47% since 10/31/24 | +8.83% since 10/31/24 | -1.02% since 10/31/24 |
| Low | 65.45 on 11/05/24 | 313.02 on 11/05/24 | 463.14 on 11/01/24 | 88.19 on 11/01/24 | 54.20 on 11/01/24 |
| High | 67.64 on 11/06/24 | 325.39 on 11/06/24 | 506.65 on 11/06/24 | 98.31 on 11/07/24 | 56.80 on 11/06/24 |
| 1-Month | |||||
| %Chg | -2.72% since 10/07/24 | +1.41% since 10/07/24 | +11.91% since 10/07/24 | +14.49% since 10/07/24 | +3.29% since 10/07/24 |
| Low | 65.35 on 10/31/24 | 310.63 on 10/30/24 | 451.11 on 10/08/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 70.98 on 10/25/24 | 329.17 on 10/11/24 | 506.65 on 11/06/24 | 98.31 on 11/07/24 | 56.80 on 11/06/24 |
| 3-Month | |||||
| %Chg | -22.27% since 08/07/24 | +3.02% since 08/07/24 | +7.75% since 08/07/24 | +30.62% since 08/07/24 | +18.71% since 08/07/24 |
| Low | 65.35 on 10/31/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 94.85 on 08/20/24 | 339.17 on 09/23/24 | 506.65 on 11/06/24 | 98.31 on 11/07/24 | 56.80 on 11/06/24 |
| 6-Month | |||||
| %Chg | -18.76% since 05/07/24 | +7.21% since 05/07/24 | +22.37% since 05/07/24 | +47.66% since 05/07/24 | +25.34% since 05/07/24 |
| Low | 65.35 on 10/31/24 | 295.30 on 06/13/24 | 412.12 on 05/08/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 94.85 on 08/20/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 98.31 on 11/07/24 | 56.80 on 11/06/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,607,065 | 172,972,768 | 127,409,472 | 114,153,312 | 112,117,616 |
| Shares Outstanding, K | 190,583 | 537,533 | 258,102 | 1,244,992 | 2,028,177 |
| Annual Sales | 2,419,230,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | 167,650,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 745,740,000 | 8,503,000,000 | 2,645,600,000 | 6,954,000,000 | 11,892,000,000 |
| Last Quarter Net Income | 106,080,000 | 2,830,000,000 | -3,593,600,000 | 1,614,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.31 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 10/29/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 10/29/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 29.22 | 16.61 | 0.00 | 19.20 | 47.82 |